Skip to search formSkip to main contentSkip to account menu

flupenthixol decanoate

Known as: 2-(4-(3-(2-trifluoromethyl-9-thioxanthenylidene)propyl)-1-piper azinyl)ethyl decanoate, Flupentixol Decanoate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Treatment of patients suffering from schizophrenia is very expensive. However, by consistently and methodically performed medical… 
1982
1982
Summary Sixty-eight depressed out-patients were allocated to treatment with either oral amitriptyline (75–225 mg/day) or… 
1979
1979
Sixty‐four chronic stabilised schizophrenics were studied for 18 months in order to assess the possible difference in therapeutic… 
1979
1979
Summary In a double-blind trial, female ‘drug-resistant’ chronic schizophrenic in-patients were given high dose or standard dose… 
1979
1979
In a 2- to 3-year open study 30 patients were treated with flupenthixol decanoate (depot form). These periodic and cyclic… 
1977
1977
The clinical and social effects of flupenthixol decanoate and fluphenazine decanoate were compared in the maintenance treatment… 
1975
1975
A double‐blind cross‐over study is reported which compares the antipsychotic properties and the side effects of depot… 
1974
1974
Forty-three schizophrenic inpatients were treated with flupenthixol decanoate or pipotiazine undecylenate during a period of 8…